Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Novitium Pharma LLC
EIR
•Novitium Pharma LLC•September 11, 2018

Novitium Pharma LLC – FDA EIR, Sep 11, 2018

Record Details

An FDA Pre-Approval Inspection (PAI) was conducted at Novitium Pharma LLC in East Windsor, NJ, from September 7 to September 11, 2018. The inspection assessed the facility's readiness for the approval of Abbreviated New Drug Application (ANDA) 211041, Nitisinone Capsules (2mg, 5mg, 10mg), under the regulatory framework of Compliance Program 7346.832, Drug Pre-approval Inspections. While no FDA Form 483 (Inspectional Observations) was issued, three significant areas of concern were discussed with firm management. These included a data integrity issue where an analyst re-processed API samples without a formal investigation, documenting the discrepancy only in a lab notebook. Additionally, in-process product labels lacked standardized instructions and a verification signature, potentially impacting material control. Lastly, two lots of Nitisinone API past their re-test dates were found with 'released' stickers in the warehouse, despite being recorded as quarantined in the paper inventory system, indicating a critical lack of synchronization between physical labeling and inventory records. Novitium Pharma LLC’s management acknowledged these findings and committed to implementing immediate corrective actions, including initiating proper investigations for data discrepancies, standardizing in-process labels to include verification, and ensuring accurate physical labeling and system synchronization for all material statuses.

Company
Novitium Pharma LLC
Inspection date
September 11, 2018
Product type
drugs
Office
New Jersey District Office
People
  • Melissa T. Roy (Regulatory Counsel at FDA with a PharmD and JD)
  • Emmanuel J. Ramos (Compliance Officer at FDA)
View Company Profile

ID · 5c159b6a-32ca-4850-8ab3-ffaeeb5030a1

Other documents for Novitium Pharma LLC
  • 483 - 2026-07-22July 22, 2026
  • 483 - 2021-07-08July 8, 2021
  • EIR - 2019-02-04February 4, 2019
  • 483 - 2019-02-04February 4, 2019
  • EIR - 2018-05-09May 9, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novitium Pharma LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.